文献速递创伤与烧伤重症综合管理与镇静镇痛

美国创伤后脓毒症的趋势、费用与死亡率:2012-2016年全国住院患者样本评估

Trends, Cost, and Mortality From Sepsis After Trauma in the United States: An Evaluation of the National Inpatient Sample of Hospitalizations, 2012-2016.
PubMed 文献 · Crit Care Med · 2020-01-01
一句话结论创伤后脓毒症约占创伤住院的6.0%,住院死亡率研究期间无改善,调整后死亡比值比在非重伤患者为4.32、重伤患者为1.39,脓毒症调整边际费用高于重伤本身。

该回顾性队列研究利用美国全国住院患者样本,分析2012至2016年创伤后住院患者中脓毒症的流行病学、费用与结局。研究期间创伤后脓毒症出院共320,450例(SE=3,642),占创伤总人群的6.0%(95%CI 5.9-6.0%)。创伤后脓毒症相关住院死亡率在研究期间无变化(p>0.40)。调整分析中,重伤(损伤严重度评分≥15)与非重伤脓毒症患者的住院死亡比值比分别为1.39(95%CI 1.31-1.47)和4.32(95%CI 4.06-4.59);脓毒症相对无脓毒症的调整边际费用为16,646美元(95%CI 16,294-16,997美元),高于重伤相对非重伤的边际费用8,851美元(95%CI 8,366-8,796美元)。作者认为需更严格地追踪创伤后脓毒症并评估医院相关授权与政策的有效性。

要点

  • 2012-2016年美国创伤后脓毒症出院320,450例(SE=3,642),占创伤总人群6.0%(95%CI 5.9-6.0%)。
  • 创伤后脓毒症相关住院死亡率在研究期间无变化(p>0.40)。
  • 调整后非重伤脓毒症患者住院死亡比值比为4.32(95%CI 4.06-4.59),重伤(ISS≥15)脓毒症患者为1.39(95%CI 1.31-1.47)。
  • 脓毒症相对无脓毒症的调整边际费用为16,646美元(95%CI 16,294-16,997美元),高于重伤相对非重伤的8,851美元(95%CI 8,366-8,796美元)。

适用人群与场景

  • 美国全国住院患者样本中2012至2016年创伤后住院并出院的患者(n=5,329,714;SE=47,447)。
  • 分析按损伤严重度评分大于或等于15分层。

研究设计与关键结果

  • 研究设计为回顾性队列研究,使用美国全国住院患者样本。
  • 2012至2016年创伤后脓毒症出院320,450例(SE=3,642),占创伤总人群6.0%(95%CI 5.9-6.0%)。
  • 创伤后脓毒症相关住院死亡率在研究期间无变化(p>0.40)。
  • 调整分析中,重伤(ISS≥15)脓毒症患者住院死亡比值比为1.39(95%CI 1.31-1.47),非重伤脓毒症患者为4.32(95%CI 4.06-4.59)。
  • 脓毒症相对无脓毒症的调整边际费用为16,646美元(95%CI 16,294-16,997美元),高于重伤相对非重伤的边际费用8,851美元(95%CI 8,366-8,796美元)。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,尽管全国脓毒症死亡率趋势多年来有所改善,但全国住院患者样本分析未在创伤人群中支持这一趋势。
  • 作者认为,无论损伤严重程度如何,创伤后脓毒症的死亡比值风险和医疗费用仍然很高。
  • 作者认为,需要更严格地追踪创伤后脓毒症,并评估医院相关授权与政策在改善创伤后脓毒症救治方面的有效性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
  • 另有 1 条提炼内容因数值无法与原文逐一核对而未列出,请以原文为准。
英文原文(摘要)· 点击展开

OBJECTIVES: Identification and outcomes in patients with sepsis have improved over the years, but little data are available in patients with trauma who develop sepsis. We aimed to examine the cost and epidemiology of sepsis in patients hospitalized after trauma.

DESIGN: Retrospective cohort study.

PATIENTS: National Inpatient Sample.

INTERVENTIONS: Sepsis was identified between 2012 and 2016 using implicit and explicit International Classification of Diseases, Ninth and Tenth Revision codes. Analyses were stratified by injury severity score greater than or equal to 15. Annual trends were modeled using generalized linear models. Survey-adjusted logistic regression was used to compare the odds for in-hospital mortality, and the average marginal effects were calculated to compare the cost of hospitalization with and without sepsis.

MEASUREMENTS AND MAIN RESULTS: There were 320,450 (SE = 3,642) traumatic injury discharges from U.S. hospitals with sepsis between 2012 and 2016, representing 6.0% (95% CI, 5.9-6.0%) of the total trauma population (n = 5,329,714; SE = 47,447). In-hospital mortality associated with sepsis after trauma did not change over the study period (p > 0.40). In adjusted analysis, severe (injury severity score ≥ 15) and nonsevere injured septic patients had an odds ratio of 1.39 (95% CI, 1.31-1.47) and 4.32 (95% CI, 4.06-4.59) for in-hospital mortality, respectively. The adjusted marginal cost for sepsis compared with nonsepsis was $16,646 (95% CI, $16,294-$16,997), and it was greater than the marginal cost for severe injury compared with nonsevere injury $8,851 (95% CI, $8,366-$8,796).

CONCLUSIONS: While national trends for sepsis mortality have improved over the years, our analysis of National Inpatient Sample did not support this trend in the trauma population. The odds risk for death after sepsis and the cost of care remained high regardless of severity of injury. More rigor is needed in tracking sepsis after trauma and evaluating the effectiveness of hospital mandates and policies to improve sepsis care in patients after trauma.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Eguia E, Bunn C, Kulshrestha S, et al. Trends, Cost, and Mortality From Sepsis After Trauma in the United States: An Evaluation of the National Inpatient Sample of Hospitalizations, 2012-2016. Crit Care Med. 2020. PMID: 32590387. doi:10.1097/CCM.0000000000004451

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。